Brief: Galera Reports Fourth Quarter And 2022 Financial Results

Obsidian Therapeutics

08/03/2023 12:41

March 8 (Reuters) - Galera Therapeutics Inc  GRTX.O :
    * GALERA REPORTS FOURTH QUARTER AND FULL YEAR 2022 FINANCIAL
RESULTS AND RECENT CORPORATE UPDATES
    * Q4 LOSS PER SHARE $0.58
    * AS OF DECEMBER 31, 2022, GALERA HAD CASH, CASH EQUIVALENTS
AND
SHORT-TERM INVESTMENTS OF $31.6 MILLION
    * Q4 EARNINGS PER SHARE VIEW $-0.54 -- REFINITIV IBES DATA

Source text for Eikon:  ID:nGNX6MJH18 
Further company coverage:  GRTX.O 

 ((Reuters.Briefs@thomsonreuters.com;))